Source: | Rabbit | Gene Id: | 1326 |
Isotype: | / | Swiss Prot: | P41279 |
purity: | Affinity purification |
Background: |
Tpl2 (tumor progression locus 2), also known as COT (cancer osaka thyroid), is a serine/threonine kinase expressed primarily in hematopoietic tissues, lung and liver (1). Over-expression of Tpl2 potentiates MAP kinase pathways through MEK1 and SEK1, as well as through MKK6 and MEK5 (2,3). Tpl2 is also engaged in NF-κB activation through NF-κB inducing kinase (NIK), or by inducing phosphorylation and degradation of the NF-κB precusor, p105 NF-κB1 (4,5). Ser400 of Tpl2 is phosphorylated in an Akt-dependent manner. This phosphorylation is required for Tpl2-induced NF-κB-dependent transcription (6). Tpl2 also activates caspase-3 by promoting the assembly of a protein complex of Apaf1 (apoptotic protease-activating factor 1), caspase-9, Tpl2, adaptor protein Tvl1 and procaspase-3 (7). |
Reactivity | Rat |
Tested applications | WB |
Clonality | Polyclonal Antibody |
Calculated MW | 60, 62 kDa |
Recommended Dilutions |
WB 1:1000
|
Immunogen | A mixture synthetic phosphorylated peptides corresponding to residues surrounding Ser400 of human, mouse and rat Tpl2 |
Storage | Store at -20°C in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Avoid freeze/thaw cycles. |
Synonym | COT, EST, ESTF, FLJ10486, TPL2, Tpl-2, c-COT |
沪ICP备15003525号-1 Copyright ©, 2013-2022, Yihyson All Rights Reserved.